Publications

Vignette
closing ESF V

03/07/2026 - PRESS RELEASES

Eurazeo closes fifth-generation secondaries programme at €2.3 billion, exceeding target


  • Vignette
    O+ progress report 2025

    15/06/2026 - PUBLICATIONS

    O+ Progress Report 2025


  • Vignette
    INVEST_FST_HOTELS_SITE.jpg

    02/07/2026 - PRESS RELEASES

    Eurazeo completes the sale of its stake in Spanish hotel group FST Hotels


  • Vignette
    INVEST_MEMO_THERAPEUTICS_SITE.jpg

    02/07/2026 - PRESS RELEASES

    Kurma Partners, a member of the Eurazeo Group and a shareholder of Memo Therapeutics AG, announces the sale of the biotech company to Ipsen for an amount that could reach up to €700 million


Vidéos

Eurazeo ambition 2024-2027

"Our ambition for 2024-2027: Become the leading private asset manager across european mid-market, growth and impact."

 

CHRISTOPHE BAVIÈRE AND WILLIAM KADOUCH-CHASSAING, CO-CEOS

Information - Individual investors

Eurazeo Investment Manager (EIM) and Eurazeo Mid Cap (EMC) are merging to form Eurazeo Global Investor (EGI)